Paired pre-NAST (core biopsy) and post-NAST (surgical) tumor samples were available for 1002 of the 1486 patients enrolled in KATHERINE, and valid, centrally determined HER2 status results were available in 845 paired samples (invalid/unknown in 157) (Fig. 1a). Here, ERBB2 is linked to neoplasm.